S 32 114th Congress Senate Crime and Law Enforcement Crimes against property Drug trafficking and controlled substances Intellectual property

Transnational Drug Trafficking Act of 2015

Introduced: January 6, 2015 See on congress.gov

Everywhere this bill has been 24 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

May 16, 2016

Became Public Law No: 114-154.

May 16, 2016

Signed by President.

May 13, 2016

Presented to President.

May 10, 2016

Motion to reconsider laid on the table Agreed to without objection.

May 10, 2016

On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2175)

May 10, 2016

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2175)

May 10, 2016

DEBATE - The House proceeded with forty minutes of debate on S. 32.

May 10, 2016

Considered under suspension of the rules. (consideration: CR H2175-2179)

May 10, 2016

Mr. Goodlatte moved to suspend the rules and pass the bill.

Nov 17, 2015

Committee on United States Senate Caucus on International Narcotics Control. Hearings held.

Nov 3, 2015

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Oct 9, 2015

Referred to the Subcommittee on Health.

Oct 8, 2015

Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Oct 8, 2015

Message on Senate action sent to the House.

Oct 8, 2015

Received in the House.

Oct 7, 2015

Passed Senate without amendment by Unanimous Consent. (consideration: CR S7223; text as passed Senate: CR S7223)

Oct 7, 2015

Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S7223; text as passed Senate: CR S7223)

Sep 17, 2015

Placed on Senate Legislative Calendar under General Orders. Calendar No. 232.

Sep 17, 2015

Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

Sep 17, 2015

Committee on the Judiciary. Ordered to be reported without amendment favorably.

Jan 13, 2015

Referred to the Committee on the Judiciary by unanimous consent.

Jan 13, 2015

Senate Committee on Finance discharged by Unanimous Consent.

Jan 6, 2015

Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S18-19)

Jan 6, 2015

Introduced in Senate

Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)

Transnational Drug Trafficking Act of 2015

(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.

Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.

In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.

(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

What's happening now May 16, 2016

Became Public Law No: 114-154.

Committees of jurisdiction 7